Search results
ACS Diagnostics, Inc.
Supplier
Author(s):
Hirotoshi Watanabe
Added:
2 years ago
Dr. Hirotoshi Watanabe (Kyoto University Graduate School of Medicine, JP) discusses the results of the STOPDAPT-2 ACS study. The aim of this study was to assess the safety of reducing dual antiplatelet therapy (DAPT) duration to 1-month after implantation of the everolimus-eluting cobalt-chromium stent (CoCr-EES) under the setting of acute coronary syndrome (ACS).
The trial showed that in ACS…
View more
ESC 2017: TROPICAL-ACS - De-Escalation of Antiplatelet Treatment in ACS Patients Undergoing PCI
Author(s):
Dirk Sibbing
Added:
6 years ago
Video
Author(s):
Ralf Stewart
Added:
4 years ago
Dr Ralph Stewart (Auckland City Hospital, Auckland, NZ) provides a comprehensive overview of the New Zealand oxygen therapy in acute coronary syndromes (NZOTACS) trial.
Questions
1. What does NZOTACS aim to address?
2. What is the study design, inclusion criteria, and end points?
3. What were your findings?
4. How does this data compare to DETO2X-AMI?
Filmed on site at ESC 2019 by…
View more
Added:
3 years ago
Treating acute coronary syndrome (ACS) patients with ticagrelor for 12 months is cost-effective, shows an analysis of the PLATO study.
“The results of the cost-effectiveness analysis show that treatment with ticagrelor is associated with a cost per quality-adjusted life year (QALY) of approximately €2,800 when compared with generic clopidogrel,” comment the researchers.
“This finding was…
View more
Author(s):
Marc P Bonaca
,
Roxana Mehran
Added:
4 years ago
Dr Marc P Bonaca (University of Colorado, Aurora, US) and Prof Roxana Mehran (Mount Sinai Hospital, New York, US) discuss the latest Clinical Data Update on TWILIGHT and TWILIGHT-ACS.
This video is a segment from a wider wrap-up of data presented at AHA 2019 on Antithrombotics. The full discussion can be viewed at https://www.radcliffecardiology.com/AHA-2019-Clinical-Data-Update-on-Ant...
…
View more
02: Role Of High-Sensitivity Cardiac Troponin In ACS
Author(s):
Santiago Garcia
,
Ankur Kalra
Added:
3 years ago
Podcast Episode
Contemporary Management of ACS
Broadcast
Added:
3 years ago
16 May 2017, Paris, France
Low risk with deferred revascularisation based on measures of intracoronary physiology
Largest real-world dataset reports on deferred revascularisation in stable angina and ACS
Deferring revascularisation based on measures of intracoronary physiology using either instantaneous wave-free ratio (iFR) or fractional flow reserve (FFR) is associated with a low risk of major…
View more
Author(s):
Juan Carlos Kaski
,
Deepak L Bhatt
,
Felicita Andreotti
,
et al
Start date:
Jun 28, 2021
View more